This session will review the antipsychotics quality measures that impact the Quality Measure component of the Nursing Home Compare Five-Star Quality Rating system. During the session, we will review how these measures are calculated and how they impact your overall Five-Star Quality Rating. The session will focus on best practices for reducing antipsychotic medications and chemical restraints in your facility and how to improve these measures using a QAPI framework with emphasis on reduction of common MDS coding errors and implementation of a facility specific Five Star road map action plan. Sample tools will be shared for driving and sustaining antipsychotic reduction efforts.
1. Understand how the antipsychotics quality measure is calculated and impacting the Five-Star Quality Rating score
2. Describe best practices for reducing antipsychotics and improving your antipsychotic quality measures
3. Describe a process for establishing priority QAPI goals and actions to improve antipsychotics reduction efforts
Shelly Maffia, MSN, MBA, RN, LNHA, QCP
Director of Regulatory Services for Proactive Medical Review & Consulting, with over 15 years of leadership and consulting experience, Shelly has held positions as DON, NHA, Corporate Nurse Consultant, and Training Positions. Currently Shelly provides consultation on regulatory compliance to nursing facilities in multiple states. Her expertise includes developing clinical training tools, policies, procedures, protocols and training programs on systems, processes and best practices. Shelly is also a QAPI Certified Professional (QCP) through the American Association of Nurse Assessment Coordinators.
All participants are eligible for up to 1.25 CEUs. Proactive Medical Review will report an equal amount of NAB credit for primary registrants for whom NAB #s are provided.
LAIN, INALA, and IHPCO Members will pay $75. Non-members will pay $125. (LAIN Samaritan Alliance members will pay $38. INALA Samaritan Alliance Members will pay $56.)